Detection of DNA fusion junctions for BCR-ABL translocations by Anchored ChromPET

Anchored ChromPET, a technique to capture and interrogate targeted sequences in the genome, has been developed to identify chromosomal aberrations and define breakpoints. Using this method, we could define the BCR-ABL1 translocation DNA breakpoint to a base-pair resolution in Philadelphia chromosome-positive samples. This DNA-based method is highly sensitive and can detect the fusion junction using samples from which it is hard to obtain RNA or cells where the RNA expression has been silenced.

[1]  Yoshiyuki Shibata,et al.  Yeast genome analysis identifies chromosomal translocation, gene conversion events and several sites of Ty element insertion , 2009, Nucleic acids research.

[2]  Reinhard Ullmann,et al.  Breakpoint analysis of balanced chromosome rearrangements by next-generation paired-end sequencing , 2010, European Journal of Human Genetics.

[3]  Jorge Cortes,et al.  Molecular biology of bcr-abl1-positive chronic myeloid leukemia. , 2009, Blood.

[4]  D. Marin,et al.  FISH mapping of Philadelphia negative BCR/ABL1 positive CML , 2008, Molecular Cytogenetics.

[5]  S. Mirkin,et al.  Replication stalling at unstable inverted repeats: Interplay between DNA hairpins and fork stabilizing proteins , 2008, Proceedings of the National Academy of Sciences.

[6]  O. Witte,et al.  The BCR-ABL story: bench to bedside and back. , 2004, Annual review of immunology.

[7]  Simona Soverini,et al.  Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. , 2006, Blood.

[8]  C. Sawyers.  Chronic myeloid leukemia. , 1999, The New England journal of medicine.

[9]  D. Leach.  Long DNA palindromes, cruciform structures, genetic instability and secondary structure repair , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[10]  S. Luo,et al.  Chimeric transcript discovery by paired-end transcriptome sequencing , 2009, Proceedings of the National Academy of Sciences.

[11]  Letizia Foroni,et al.  Technical aspects and clinical applications of measuring BCR‐ABL1 transcripts number in chronic myeloid leukemia , 2009, American journal of hematology.

[12]  J. Maguire,et al.  Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing , 2009, Nature Biotechnology.

[13]  R. Gale,et al.  Chronic myeloid leukemia. , 1992, The American journal of medicine.

[14]  E. Campo,et al.  Chimeric BCR/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myelocytic leukemia. , 2003, Cancer genetics and cytogenetics.

[15]  J. Sessions.  Chronic myeloid leukemia in 2007. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[16]  E. Liu,et al.  Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses. , 2009, Genome research.

[17]  J. Goldman,et al.  Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation. , 1996, Blood.

[18]  R. Bruzzone,et al.  Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia. , 2005, Cancer genetics and cytogenetics.

[19]  F. Pasquali,et al.  Molecular monitoring of residual disease in chronic myeloid leukemia by genomic DNA compared with conventional mRNA analysis. , 2009, The Journal of molecular diagnostics : JMD.

[20]  J. Bedford,et al.  Polymerase chain reaction-based suppression of repetitive sequences in whole chromosome painting probes for FISH , 2005, Chromosome Research.

[21]  T. Shaikh,et al.  Chromosomal instability mediated by non-B DNA: cruciform conformation and not DNA sequence is responsible for recurrent translocation in humans. , 2009, Genome research.

[22]  A. Børresen-Dale,et al.  COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES , 2009, Nature.

[23]  Yijun Ruan,et al.  Paired-end diTagging for transcriptome and genome analysis. , 2006, Current protocols in molecular biology.

[24]  M. Leversha,et al.  Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. , 2000, Blood.

[25]  R. Sokolic,et al.  Conventional cytogenetics and FISH in the detection of BCR/ABL fusion in chronic myeloid leukemia (CML). , 2006, Experimental and molecular pathology.

[26]  B. Druker,et al.  Translation of the Philadelphia chromosome into therapy for CML. , 2008, Blood.

[27]  A. Venco,et al.  Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia , 2008, Genes, chromosomes & cancer.

[28]  A. Green,et al.  Philadelphia‐negative chronic myeloid leukaemia: detection by FISH of BCR‐ABL fusion gene localized either to chromosome 9 or chromosome 22 , 1994, British journal of haematology.

[29]  J. Melo,et al.  BCR-ABL in Chronic Myelogenous Leukemia – How Does It Work? , 2008, Acta Haematologica.

[30]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..